Growth Hormone Secretagogues
Growth hormone secretagogues are studied for their effect on the body’s own GH and IGF-1 release rather than supplying hormone directly. Evidence ranges from approved clinical agents to compounds with sparse human data.
CJC-1295
MixedA synthetic analog of growth hormone-releasing hormone (GHRH) designed for a longer duration of action, studied for stimulating the body's own GH release.
Ipamorelin
MixedA selective ghrelin-receptor agonist studied as a growth hormone secretagogue — it prompts the pituitary to release the body's own growth hormone.
MK-677
MixedAn orally active ghrelin-receptor agonist (growth hormone secretagogue) that raises GH and IGF-1; a small molecule rather than a peptide, with some human study data.
Sermorelin
MixedA GHRH analog (the 1-29 fragment) with a history of approved diagnostic/clinical use, now commonly compounded as a growth hormone secretagogue.